New 'Micro' eye surgery could ease glaucoma treatment
NCT ID NCT06213805
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new, less invasive surgery called MIMS for people with glaucoma. The goal was to see if it lowers eye pressure as well as traditional surgery but with fewer side effects. 23 adults with glaucoma took part. The results will help doctors understand if MIMS is a safer option for managing this chronic eye disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC ANGLE CLOSURE GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinique Thiers
Bordeaux, 33100, France
-
Fondation Rothschild
Paris, 75019, France
-
Hôpital Privé de la Baie
Avranches, 50300, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a bangkok community eye check reveal hidden glaucoma risks?
- AI eye exam: a new hope for early glaucoma detection?
- Can a tiny eye implant replace glaucoma drops?
- Can a new tube implant surgery outperform standard glaucoma surgery?
- Can a laser treat glaucoma without touching the eye?
- Could your personality predict glaucoma drug side effects?